Joanna M Streck, Ju-Whei Lee, Angela Wangari Walter, Rachel L Rosen, Ilana F Gareen, Sheetal Mehta Kircher, Benjamin A Herman, Ruth C Carlos, Shaji Kumar, Ingrid A Mayer, Nabil F Saba, Timothy S Fenske, Joel W Neal, Michael B Atkins, F Stephen Hodi, Christos E Kyriakopoulos, Clare Tempany, Tait D Shanafelt, Lynne I Wagner, Stephanie R Land, Elyse R Park, Jamie S Ostroff
BACKGROUND: While cigarette smoking has declined among the US general population, sale and use of non-cigarette alternative tobacco products (ATPs; e.g., e-cigarettes, cigars) and dual use of cigarettes/ATPs are rising. Little is known about ATP use patterns in cancer survivors enrolled in clinical trials. We investigated prevalence of tobacco product use, and factors associated with past 30-day use, among cancer patients in national trials. METHODS: Cancer survivors (N=756) enrolled in 9 ECOG-ACRIN clinical trials (2017-2021) completed a modified Cancer Patient Tobacco Use Questionnaire (C-TUQ) which assessed baseline cigarette and ATP use since cancer diagnosis and in the past 30-days (30d)...
July 6, 2023: Cancer Epidemiology, Biomarkers & Prevention